N/A
N=121
Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic
Bereavement · Severe Grief Reaction
Bottom Line
View on ClinicalTrials.gov: NCT04588415 ↗Enrolled (actual)
121
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: The Inventory for Complicated Grief-revised (ICG-r) Score at 6 Months Post-death — 35; 86 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Bereavement Virtual Support Group (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Ottawa Hospital Research Institute
- Primary completion
- Feb 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Inventory for Complicated Grief-revised (ICG-r) Score at 6 Months Post-death |
35; 86 | — |
| PRIMARY The Inventory for Complicated Grief-revised (ICG-r) Score at 12 Months Post-death |
32; 79 | — |
| PRIMARY Change in ICG-r Score From 6 Months to 12 Months Post-death |
-0.01 | — |
| PRIMARY Qualitative Interviews Post-Virtual Support Group |
— | — |
Summary
This is a feasibility study taking place at The Ottawa Hospital (TOH), Hôpital Montfort, and Queensway Carleton Hospital that seeks to evaluate the impact of the COVID-19 pandemic on family member bereavement and study the effect of virtual support groups on reducing risk of developing Severe Grief Reaction (SGR). This project is inviting family members of deceased patients at either of the three before mentioned sites to enroll in this study.
Eligibility Criteria
Inclusion Criteria
- Family Members of deceased patients from The Ottawa Hospital, Queensway-Carleton Hospital, and Hôpital Montfort
Exclusion Criteria
- Anyone who is unable to participate in a virtual intervention
Data sourced from ClinicalTrials.gov (NCT04588415). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.